Follicular lymphoma: open trials in Finland

• NCT06549595

  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  Trial Treatment · Phase 3 · AstraZeneca

  Helsinki · Kuopio · Tampere

  Registry updated 2026-10-21

• 2023-508196-36-00

  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Trial Treatment · Phase 2 · Karolinska University Hospital

  HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-06-16

• NCT04844866

  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  HUS-Yhtymae, Helsinki · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Varsinais-Suomen hyvinvointialue, Turku

  Registry updated 2026-06-10

• NCT06911502

  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  Trial Treatment · Phase 3 · Celgene

  HUS-Yhtymae, Helsinki · Oulu University Hospital, Oulu · Turku University Hospital, Turku

  Registry updated 2026-05-20

• NCT05849857

  Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

  Trial Treatment · Phase 2 · Oslo University Hospital

  Helsinki University Hospital, Helsinki

  Registry updated 2023-11-01

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error